From proteins to protein interacting drugs.
British Bio-technology Ltd, Oxford, UK.
B
B
Richards
D000595:Amino Acid Sequence; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003196:Computer Graphics; D015195:Drug Design; D006023:Glycoproteins / Q000627:therapeutic use; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D008667:Metalloproteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003012:Microbial Collagenase / Q000037:antagonists & inhibitors; D008969:Molecular Sequence Data; D009362:Neoplasm Metastasis / Q000517:prevention & control; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors; D011506:Proteins; D019714:Tissue Inhibitor of Metalloproteinases
D000970:Antineoplastic Agents; D006023:Glycoproteins; D008667:Metalloproteins; D010972:Platelet Activating Factor; D011506:Proteins; D019714:Tissue Inhibitor of Metalloproteinases; D008666:Metalloendopeptidases; D003012:Microbial Collagenase